Other OTC - Delayed Quote USD

Aurora Spine Corporation (ASAPF)

0.1951 -0.0059 (-2.96%)
As of 2:06 PM EDT. Market Open.
Loading Chart for ASAPF
DELL
  • Previous Close 0.2010
  • Open 0.1763
  • Bid --
  • Ask --
  • Day's Range 0.1763 - 0.1951
  • 52 Week Range 0.1700 - 0.3430
  • Volume 7,400
  • Avg. Volume 11,752
  • Market Cap (intraday) 15.651M
  • Beta (5Y Monthly) 0.70
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0200
  • Earnings Date May 13, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Aurora Spine Corporation, through its subsidiary, Aurora Spine, Inc., engages in the development and distribution of minimally invasive interspinous fusion systems and devices in Canada. The company offers interspinous process lumbar fusion devices, such as the ZIP, ZIP ULTRA, ZIP LP, and ZIP-51 for patients suffering from degenerative disc diseases; and Ti-Coated polyether ether ketone interbody cages, which provide spacing and stability between the vertebrae while bone grows to complete the fusion process. It also provides sterile-packed titanium plasma spray coated spinal infusion implants for bone growth, as well as interbody products, such as EOS, VOX, Echo, Echo SD, and EchoXL for the lumbar section of the spine, and discovery for cervical procedures. In addition, the company provides SOLO, an anterior lumbar interbody fusion 3D printed stand-alone fusion device, which is an integrated plate and spacer system that helps to preserve the natural anatomic profile while providing spinal column support and stability; and SiLo, a posterior fusion device for the sacroiliac joint. Further, it offers DEXA-C, a cervical interbody system, which is a porous 3D-printed intervertebral body fusion device that incorporates low-, mid-, or high-density lattice pattern options to support the matching of patients' bone quality, as well as DEXA SOLO-L spinal fusion system. Aurora Spine Corporation was founded in 2013 and is headquartered in Toronto, Canada.

www.aurora-spine.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: ASAPF

Performance Overview: ASAPF

Trailing total returns as of 5/14/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

ASAPF
32.74%
S&P/TSX Composite index
6.05%

1-Year Return

ASAPF
21.98%
S&P/TSX Composite index
8.85%

3-Year Return

ASAPF
68.54%
S&P/TSX Composite index
16.15%

5-Year Return

ASAPF
25.67%
S&P/TSX Composite index
37.25%

Compare To: ASAPF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ASAPF

Valuation Measures

Annual
As of 5/13/2024
  • Market Cap

    16.13M

  • Enterprise Value

    19.01M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.98

  • Price/Book (mrq)

    2.94

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -11.57%

  • Return on Assets (ttm)

    -8.46%

  • Return on Equity (ttm)

    -34.96%

  • Revenue (ttm)

    14.52M

  • Net Income Avi to Common (ttm)

    -1.68M

  • Diluted EPS (ttm)

    -0.0200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    766.83k

  • Total Debt/Equity (mrq)

    68.82%

  • Levered Free Cash Flow (ttm)

    -963.71k

Research Analysis: ASAPF

Company Insights: ASAPF

Research Reports: ASAPF

People Also Watch